|
1
|
Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection.
|
Retina
|
2008
|
2.22
|
|
2
|
Association between retinal thickness measured by spectral-domain optical coherence tomography (OCT) and rod-mediated dark adaptation in non-exudative age-related maculopathy.
|
Br J Ophthalmol
|
2011
|
1.48
|
|
3
|
Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy.
|
Am J Ophthalmol
|
2006
|
1.43
|
|
4
|
Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy.
|
Invest Ophthalmol Vis Sci
|
2006
|
1.14
|
|
5
|
Ocular trauma from paintball-pellet war games.
|
South Med J
|
2002
|
0.99
|
|
6
|
Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group.
|
Ophthalmology
|
2010
|
0.89
|
|
7
|
Incidence of hemorrhagic complications after intravitreal bevacizumab (avastin) or ranibizumab (lucentis) injections on systemically anticoagulated patients.
|
Retina
|
2010
|
0.86
|
|
8
|
Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.
|
Am J Ophthalmol
|
2005
|
0.86
|
|
9
|
An association between central serous chorioretinopathy and gastroesophageal reflux disease.
|
Am J Ophthalmol
|
2004
|
0.84
|
|
10
|
Retinochoroidal collateral veins protect against anterior segment neovascularization after central retinal vein occlusion.
|
Arch Ophthalmol
|
2003
|
0.82
|
|
11
|
Incidence of endophthalmitis following 20-gauge and 25-gauge vitrectomy.
|
Retina
|
2008
|
0.80
|
|
12
|
Risk factors for severe vision loss immediately after transpupillary thermotherapy for occult subfoveal choroidal neovascularization.
|
Ophthalmic Surg Lasers Imaging
|
2008
|
0.77
|
|
13
|
Macular holes associated with diabetic tractional retinal detachments.
|
Ophthalmic Surg Lasers Imaging
|
2008
|
0.75
|